We aimed to investigate the safety , pharmacokinetics , and therapeutic potential of specific polyclonal immunoglobulin equine F ( ab ' ) fragments raised against influenza A/Vietnam/1194 / 2004 virus ( H5N1 subtype ) in healthy volunteers .